nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Mitoxantrone—sarcoma	0.114	0.142	CbGbCtD
Ofloxacin—TOP2A—Epirubicin—sarcoma	0.092	0.115	CbGbCtD
Ofloxacin—TOP2A—Etoposide—sarcoma	0.0717	0.0893	CbGbCtD
Ofloxacin—ABCC1—Dactinomycin—sarcoma	0.0704	0.0877	CbGbCtD
Ofloxacin—SLC22A5—Dactinomycin—sarcoma	0.0669	0.0834	CbGbCtD
Ofloxacin—ABCC1—Mitoxantrone—sarcoma	0.063	0.0785	CbGbCtD
Ofloxacin—ABCC1—Epirubicin—sarcoma	0.051	0.0635	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—sarcoma	0.0489	0.0609	CbGbCtD
Ofloxacin—ABCC1—Vincristine—sarcoma	0.0434	0.054	CbGbCtD
Ofloxacin—ABCC1—Etoposide—sarcoma	0.0397	0.0495	CbGbCtD
Ofloxacin—ABCC2—Vincristine—sarcoma	0.0321	0.04	CbGbCtD
Ofloxacin—ABCC2—Etoposide—sarcoma	0.0294	0.0366	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—sarcoma	0.0271	0.0338	CbGbCtD
Ofloxacin—CYP1A2—Dacarbazine—sarcoma	0.0224	0.0279	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—sarcoma	0.0201	0.025	CbGbCtD
Ofloxacin—CYP1A2—Etoposide—sarcoma	0.011	0.0137	CbGbCtD
Ofloxacin—SLC22A4—larynx—sarcoma	0.00254	0.181	CbGeAlD
Ofloxacin—SLC22A4—mammary gland—sarcoma	0.000822	0.0586	CbGeAlD
Ofloxacin—TOP2A—Vindesine—Vincristine—sarcoma	0.000807	0.191	CbGdCrCtD
Ofloxacin—TOP2A—myometrium—sarcoma	0.000729	0.052	CbGeAlD
Ofloxacin—SLC22A4—myometrium—sarcoma	0.000583	0.0416	CbGeAlD
Ofloxacin—SLC22A5—mammary gland—sarcoma	0.000544	0.0388	CbGeAlD
Ofloxacin—SLC22A4—seminal vesicle—sarcoma	0.000527	0.0376	CbGeAlD
Ofloxacin—TOP2A—Vinorelbine—Vincristine—sarcoma	0.00051	0.121	CbGdCrCtD
Ofloxacin—TOP2A—Teniposide—Etoposide—sarcoma	0.000509	0.121	CbGdCrCtD
Ofloxacin—TOP2A—Podofilox—Etoposide—sarcoma	0.000509	0.121	CbGdCrCtD
Ofloxacin—TOP2A—uterus—sarcoma	0.000473	0.0337	CbGeAlD
Ofloxacin—ABCC1—myometrium—sarcoma	0.000439	0.0313	CbGeAlD
Ofloxacin—TOP2A—tendon—sarcoma	0.000414	0.0295	CbGeAlD
Ofloxacin—TOP2A—bone marrow—sarcoma	0.000401	0.0286	CbGeAlD
Ofloxacin—ABCC1—seminal vesicle—sarcoma	0.000397	0.0283	CbGeAlD
Ofloxacin—SLC22A5—myometrium—sarcoma	0.000386	0.0275	CbGeAlD
Ofloxacin—TOP2A—Vinblastine—Vincristine—sarcoma	0.00035	0.083	CbGdCrCtD
Ofloxacin—SLC22A5—seminal vesicle—sarcoma	0.000349	0.0249	CbGeAlD
Ofloxacin—TOP2A—testis—sarcoma	0.000343	0.0245	CbGeAlD
Ofloxacin—SLC22A4—tendon—sarcoma	0.000332	0.0236	CbGeAlD
Ofloxacin—SLC22A4—bone marrow—sarcoma	0.000321	0.0229	CbGeAlD
Ofloxacin—CYP1A2—hematopoietic system—sarcoma	0.0003	0.0214	CbGeAlD
Ofloxacin—SLC22A5—skin of body—sarcoma	0.000288	0.0206	CbGeAlD
Ofloxacin—ABCC1—cardiac atrium—sarcoma	0.000286	0.0204	CbGeAlD
Ofloxacin—ABCC1—uterus—sarcoma	0.000285	0.0203	CbGeAlD
Ofloxacin—ABCC2—tendon—sarcoma	0.000283	0.0202	CbGeAlD
Ofloxacin—TOP2A—Doxorubicin—Epirubicin—sarcoma	0.000266	0.0629	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Epirubicin—sarcoma	0.000266	0.0629	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Epirubicin—sarcoma	0.000266	0.0629	CbGdCrCtD
Ofloxacin—SLC22A5—cardiac atrium—sarcoma	0.000252	0.0179	CbGeAlD
Ofloxacin—ABCC1—tendon—sarcoma	0.000249	0.0178	CbGeAlD
Ofloxacin—TOP2A—lymph node—sarcoma	0.000249	0.0177	CbGeAlD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—sarcoma	0.000246	0.0582	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—sarcoma	0.000246	0.0582	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—sarcoma	0.000246	0.0582	CbGdCrCtD
Ofloxacin—ABCC2—testis—sarcoma	0.000234	0.0167	CbGeAlD
Ofloxacin—ABCC2—liver—sarcoma	0.000222	0.0158	CbGeAlD
Ofloxacin—SLC22A5—tendon—sarcoma	0.000219	0.0156	CbGeAlD
Ofloxacin—ABCC1—testis—sarcoma	0.000207	0.0147	CbGeAlD
Ofloxacin—SLC22A4—lymph node—sarcoma	0.000199	0.0142	CbGeAlD
Ofloxacin—ABCC1—liver—sarcoma	0.000195	0.0139	CbGeAlD
Ofloxacin—SLC22A5—testis—sarcoma	0.000182	0.013	CbGeAlD
Ofloxacin—SLC22A5—liver—sarcoma	0.000172	0.0122	CbGeAlD
Ofloxacin—ABCC2—lymph node—sarcoma	0.00017	0.0121	CbGeAlD
Ofloxacin—CYP1A2—liver—sarcoma	0.000156	0.0111	CbGeAlD
Ofloxacin—ABCC1—lymph node—sarcoma	0.00015	0.0107	CbGeAlD
Ofloxacin—SLC22A5—lymph node—sarcoma	0.000132	0.00939	CbGeAlD
Ofloxacin—Headache—Thiotepa—sarcoma	9.18e-05	0.000512	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Epirubicin—sarcoma	9.17e-05	0.000512	CcSEcCtD
Ofloxacin—Rash—Dactinomycin—sarcoma	9.17e-05	0.000512	CcSEcCtD
Ofloxacin—Decreased appetite—Etoposide—sarcoma	9.15e-05	0.000511	CcSEcCtD
Ofloxacin—Pancytopenia—Doxorubicin—sarcoma	9.12e-05	0.000509	CcSEcCtD
Ofloxacin—Renal failure—Epirubicin—sarcoma	9.09e-05	0.000508	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Etoposide—sarcoma	9.09e-05	0.000507	CcSEcCtD
Ofloxacin—Asthenia—Mitoxantrone—sarcoma	9.08e-05	0.000507	CcSEcCtD
Ofloxacin—Fatigue—Etoposide—sarcoma	9.07e-05	0.000507	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Epirubicin—sarcoma	9.07e-05	0.000506	CcSEcCtD
Ofloxacin—Jaundice—Epirubicin—sarcoma	9.02e-05	0.000503	CcSEcCtD
Ofloxacin—Stomatitis—Epirubicin—sarcoma	9.02e-05	0.000503	CcSEcCtD
Ofloxacin—Pain—Etoposide—sarcoma	9e-05	0.000502	CcSEcCtD
Ofloxacin—Constipation—Etoposide—sarcoma	9e-05	0.000502	CcSEcCtD
Ofloxacin—Conjunctivitis—Epirubicin—sarcoma	8.99e-05	0.000502	CcSEcCtD
Ofloxacin—Dysuria—Doxorubicin—sarcoma	8.98e-05	0.000501	CcSEcCtD
Ofloxacin—Neutropenia—Doxorubicin—sarcoma	8.98e-05	0.000501	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Doxorubicin—sarcoma	8.92e-05	0.000498	CcSEcCtD
Ofloxacin—Diarrhoea—Vincristine—sarcoma	8.89e-05	0.000496	CcSEcCtD
Ofloxacin—Pollakiuria—Doxorubicin—sarcoma	8.87e-05	0.000495	CcSEcCtD
Ofloxacin—Haematuria—Epirubicin—sarcoma	8.82e-05	0.000492	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Doxorubicin—sarcoma	8.76e-05	0.000489	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Epirubicin—sarcoma	8.75e-05	0.000488	CcSEcCtD
Ofloxacin—Epistaxis—Epirubicin—sarcoma	8.72e-05	0.000487	CcSEcCtD
Ofloxacin—Nausea—Thiotepa—sarcoma	8.7e-05	0.000486	CcSEcCtD
Ofloxacin—Weight decreased—Doxorubicin—sarcoma	8.68e-05	0.000485	CcSEcCtD
Ofloxacin—Sinusitis—Epirubicin—sarcoma	8.68e-05	0.000484	CcSEcCtD
Ofloxacin—Feeling abnormal—Etoposide—sarcoma	8.67e-05	0.000484	CcSEcCtD
Ofloxacin—Hyperglycaemia—Doxorubicin—sarcoma	8.66e-05	0.000483	CcSEcCtD
Ofloxacin—Diarrhoea—Mitoxantrone—sarcoma	8.66e-05	0.000483	CcSEcCtD
Ofloxacin—Nausea—Dactinomycin—sarcoma	8.64e-05	0.000482	CcSEcCtD
Ofloxacin—Agranulocytosis—Epirubicin—sarcoma	8.63e-05	0.000482	CcSEcCtD
Ofloxacin—Pneumonia—Doxorubicin—sarcoma	8.61e-05	0.000481	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Etoposide—sarcoma	8.61e-05	0.00048	CcSEcCtD
Ofloxacin—Dizziness—Vincristine—sarcoma	8.59e-05	0.00048	CcSEcCtD
Ofloxacin—Drowsiness—Doxorubicin—sarcoma	8.56e-05	0.000478	CcSEcCtD
Ofloxacin—Infestation—Doxorubicin—sarcoma	8.56e-05	0.000478	CcSEcCtD
Ofloxacin—Infestation NOS—Doxorubicin—sarcoma	8.56e-05	0.000478	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	8.48e-05	0.000474	CcSEcCtD
Ofloxacin—Bradycardia—Epirubicin—sarcoma	8.45e-05	0.000472	CcSEcCtD
Ofloxacin—Renal failure—Doxorubicin—sarcoma	8.41e-05	0.00047	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Doxorubicin—sarcoma	8.39e-05	0.000468	CcSEcCtD
Ofloxacin—Urticaria—Etoposide—sarcoma	8.36e-05	0.000467	CcSEcCtD
Ofloxacin—Haemoglobin—Epirubicin—sarcoma	8.35e-05	0.000466	CcSEcCtD
Ofloxacin—Stomatitis—Doxorubicin—sarcoma	8.34e-05	0.000466	CcSEcCtD
Ofloxacin—Jaundice—Doxorubicin—sarcoma	8.34e-05	0.000466	CcSEcCtD
Ofloxacin—Rhinitis—Epirubicin—sarcoma	8.32e-05	0.000465	CcSEcCtD
Ofloxacin—Abdominal pain—Etoposide—sarcoma	8.32e-05	0.000464	CcSEcCtD
Ofloxacin—Body temperature increased—Etoposide—sarcoma	8.32e-05	0.000464	CcSEcCtD
Ofloxacin—Conjunctivitis—Doxorubicin—sarcoma	8.32e-05	0.000464	CcSEcCtD
Ofloxacin—Haemorrhage—Epirubicin—sarcoma	8.3e-05	0.000464	CcSEcCtD
Ofloxacin—Hepatitis—Epirubicin—sarcoma	8.3e-05	0.000464	CcSEcCtD
Ofloxacin—Hypoaesthesia—Epirubicin—sarcoma	8.26e-05	0.000461	CcSEcCtD
Ofloxacin—Vomiting—Vincristine—sarcoma	8.26e-05	0.000461	CcSEcCtD
Ofloxacin—Pharyngitis—Epirubicin—sarcoma	8.24e-05	0.00046	CcSEcCtD
Ofloxacin—Urinary tract disorder—Epirubicin—sarcoma	8.2e-05	0.000458	CcSEcCtD
Ofloxacin—Rash—Vincristine—sarcoma	8.19e-05	0.000457	CcSEcCtD
Ofloxacin—Dermatitis—Vincristine—sarcoma	8.18e-05	0.000457	CcSEcCtD
Ofloxacin—Oedema peripheral—Epirubicin—sarcoma	8.18e-05	0.000457	CcSEcCtD
Ofloxacin—Haematuria—Doxorubicin—sarcoma	8.16e-05	0.000456	CcSEcCtD
Ofloxacin—Connective tissue disorder—Epirubicin—sarcoma	8.16e-05	0.000456	CcSEcCtD
Ofloxacin—Urethral disorder—Epirubicin—sarcoma	8.14e-05	0.000454	CcSEcCtD
Ofloxacin—Headache—Vincristine—sarcoma	8.14e-05	0.000454	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Doxorubicin—sarcoma	8.09e-05	0.000452	CcSEcCtD
Ofloxacin—Epistaxis—Doxorubicin—sarcoma	8.07e-05	0.000451	CcSEcCtD
Ofloxacin—Vomiting—Mitoxantrone—sarcoma	8.04e-05	0.000449	CcSEcCtD
Ofloxacin—Sinusitis—Doxorubicin—sarcoma	8.03e-05	0.000448	CcSEcCtD
Ofloxacin—Visual impairment—Epirubicin—sarcoma	8e-05	0.000447	CcSEcCtD
Ofloxacin—Agranulocytosis—Doxorubicin—sarcoma	7.99e-05	0.000446	CcSEcCtD
Ofloxacin—Rash—Mitoxantrone—sarcoma	7.98e-05	0.000445	CcSEcCtD
Ofloxacin—Dermatitis—Mitoxantrone—sarcoma	7.97e-05	0.000445	CcSEcCtD
Ofloxacin—Headache—Mitoxantrone—sarcoma	7.93e-05	0.000442	CcSEcCtD
Ofloxacin—Erythema multiforme—Epirubicin—sarcoma	7.85e-05	0.000438	CcSEcCtD
Ofloxacin—Bradycardia—Doxorubicin—sarcoma	7.82e-05	0.000437	CcSEcCtD
Ofloxacin—Eye disorder—Epirubicin—sarcoma	7.76e-05	0.000433	CcSEcCtD
Ofloxacin—Hypersensitivity—Etoposide—sarcoma	7.75e-05	0.000433	CcSEcCtD
Ofloxacin—Tinnitus—Epirubicin—sarcoma	7.74e-05	0.000432	CcSEcCtD
Ofloxacin—Haemoglobin—Doxorubicin—sarcoma	7.72e-05	0.000431	CcSEcCtD
Ofloxacin—Nausea—Vincristine—sarcoma	7.72e-05	0.000431	CcSEcCtD
Ofloxacin—Cardiac disorder—Epirubicin—sarcoma	7.71e-05	0.00043	CcSEcCtD
Ofloxacin—Flushing—Epirubicin—sarcoma	7.71e-05	0.00043	CcSEcCtD
Ofloxacin—Rhinitis—Doxorubicin—sarcoma	7.7e-05	0.00043	CcSEcCtD
Ofloxacin—Haemorrhage—Doxorubicin—sarcoma	7.68e-05	0.000429	CcSEcCtD
Ofloxacin—Hepatitis—Doxorubicin—sarcoma	7.68e-05	0.000429	CcSEcCtD
Ofloxacin—Hypoaesthesia—Doxorubicin—sarcoma	7.64e-05	0.000427	CcSEcCtD
Ofloxacin—Pharyngitis—Doxorubicin—sarcoma	7.63e-05	0.000426	CcSEcCtD
Ofloxacin—Urinary tract disorder—Doxorubicin—sarcoma	7.59e-05	0.000424	CcSEcCtD
Ofloxacin—Oedema peripheral—Doxorubicin—sarcoma	7.57e-05	0.000423	CcSEcCtD
Ofloxacin—Asthenia—Etoposide—sarcoma	7.55e-05	0.000422	CcSEcCtD
Ofloxacin—Connective tissue disorder—Doxorubicin—sarcoma	7.55e-05	0.000421	CcSEcCtD
Ofloxacin—Angiopathy—Epirubicin—sarcoma	7.53e-05	0.000421	CcSEcCtD
Ofloxacin—Urethral disorder—Doxorubicin—sarcoma	7.53e-05	0.00042	CcSEcCtD
Ofloxacin—Nausea—Mitoxantrone—sarcoma	7.52e-05	0.00042	CcSEcCtD
Ofloxacin—Immune system disorder—Epirubicin—sarcoma	7.5e-05	0.000419	CcSEcCtD
Ofloxacin—Mediastinal disorder—Epirubicin—sarcoma	7.48e-05	0.000418	CcSEcCtD
Ofloxacin—Chills—Epirubicin—sarcoma	7.45e-05	0.000416	CcSEcCtD
Ofloxacin—Pruritus—Etoposide—sarcoma	7.45e-05	0.000416	CcSEcCtD
Ofloxacin—Arrhythmia—Epirubicin—sarcoma	7.42e-05	0.000414	CcSEcCtD
Ofloxacin—Visual impairment—Doxorubicin—sarcoma	7.4e-05	0.000413	CcSEcCtD
Ofloxacin—Alopecia—Epirubicin—sarcoma	7.34e-05	0.00041	CcSEcCtD
Ofloxacin—Mental disorder—Epirubicin—sarcoma	7.27e-05	0.000406	CcSEcCtD
Ofloxacin—Erythema multiforme—Doxorubicin—sarcoma	7.26e-05	0.000406	CcSEcCtD
Ofloxacin—Malnutrition—Epirubicin—sarcoma	7.23e-05	0.000404	CcSEcCtD
Ofloxacin—Erythema—Epirubicin—sarcoma	7.23e-05	0.000404	CcSEcCtD
Ofloxacin—Diarrhoea—Etoposide—sarcoma	7.2e-05	0.000402	CcSEcCtD
Ofloxacin—Eye disorder—Doxorubicin—sarcoma	7.18e-05	0.000401	CcSEcCtD
Ofloxacin—Tinnitus—Doxorubicin—sarcoma	7.16e-05	0.0004	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—sarcoma	7.13e-05	0.000398	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—sarcoma	7.13e-05	0.000398	CcSEcCtD
Ofloxacin—Flatulence—Epirubicin—sarcoma	7.12e-05	0.000398	CcSEcCtD
Ofloxacin—Tension—Epirubicin—sarcoma	7.09e-05	0.000396	CcSEcCtD
Ofloxacin—Dysgeusia—Epirubicin—sarcoma	7.08e-05	0.000395	CcSEcCtD
Ofloxacin—Nervousness—Epirubicin—sarcoma	7.02e-05	0.000392	CcSEcCtD
Ofloxacin—Back pain—Epirubicin—sarcoma	6.99e-05	0.00039	CcSEcCtD
Ofloxacin—Angiopathy—Doxorubicin—sarcoma	6.97e-05	0.000389	CcSEcCtD
Ofloxacin—Dizziness—Etoposide—sarcoma	6.96e-05	0.000389	CcSEcCtD
Ofloxacin—Muscle spasms—Epirubicin—sarcoma	6.95e-05	0.000388	CcSEcCtD
Ofloxacin—Immune system disorder—Doxorubicin—sarcoma	6.94e-05	0.000387	CcSEcCtD
Ofloxacin—Mediastinal disorder—Doxorubicin—sarcoma	6.92e-05	0.000387	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—sarcoma	6.89e-05	0.000385	CcSEcCtD
Ofloxacin—Arrhythmia—Doxorubicin—sarcoma	6.86e-05	0.000383	CcSEcCtD
Ofloxacin—Vision blurred—Epirubicin—sarcoma	6.81e-05	0.00038	CcSEcCtD
Ofloxacin—Alopecia—Doxorubicin—sarcoma	6.79e-05	0.000379	CcSEcCtD
Ofloxacin—Mental disorder—Doxorubicin—sarcoma	6.73e-05	0.000376	CcSEcCtD
Ofloxacin—Ill-defined disorder—Epirubicin—sarcoma	6.71e-05	0.000374	CcSEcCtD
Ofloxacin—Vomiting—Etoposide—sarcoma	6.69e-05	0.000374	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—sarcoma	6.69e-05	0.000373	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—sarcoma	6.69e-05	0.000373	CcSEcCtD
Ofloxacin—Anaemia—Epirubicin—sarcoma	6.68e-05	0.000373	CcSEcCtD
Ofloxacin—Agitation—Epirubicin—sarcoma	6.64e-05	0.000371	CcSEcCtD
Ofloxacin—Rash—Etoposide—sarcoma	6.64e-05	0.00037	CcSEcCtD
Ofloxacin—Dermatitis—Etoposide—sarcoma	6.63e-05	0.00037	CcSEcCtD
Ofloxacin—Headache—Etoposide—sarcoma	6.59e-05	0.000368	CcSEcCtD
Ofloxacin—Flatulence—Doxorubicin—sarcoma	6.59e-05	0.000368	CcSEcCtD
Ofloxacin—Tension—Doxorubicin—sarcoma	6.56e-05	0.000366	CcSEcCtD
Ofloxacin—Dysgeusia—Doxorubicin—sarcoma	6.55e-05	0.000366	CcSEcCtD
Ofloxacin—Malaise—Epirubicin—sarcoma	6.52e-05	0.000364	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—sarcoma	6.5e-05	0.000363	CcSEcCtD
Ofloxacin—Vertigo—Epirubicin—sarcoma	6.49e-05	0.000363	CcSEcCtD
Ofloxacin—Syncope—Epirubicin—sarcoma	6.48e-05	0.000362	CcSEcCtD
Ofloxacin—Leukopenia—Epirubicin—sarcoma	6.47e-05	0.000361	CcSEcCtD
Ofloxacin—Back pain—Doxorubicin—sarcoma	6.47e-05	0.000361	CcSEcCtD
Ofloxacin—Muscle spasms—Doxorubicin—sarcoma	6.43e-05	0.000359	CcSEcCtD
Ofloxacin—Palpitations—Epirubicin—sarcoma	6.39e-05	0.000357	CcSEcCtD
Ofloxacin—Loss of consciousness—Epirubicin—sarcoma	6.35e-05	0.000355	CcSEcCtD
Ofloxacin—Cough—Epirubicin—sarcoma	6.31e-05	0.000352	CcSEcCtD
Ofloxacin—Vision blurred—Doxorubicin—sarcoma	6.3e-05	0.000352	CcSEcCtD
Ofloxacin—Nausea—Etoposide—sarcoma	6.25e-05	0.000349	CcSEcCtD
Ofloxacin—Hypertension—Epirubicin—sarcoma	6.24e-05	0.000348	CcSEcCtD
Ofloxacin—Ill-defined disorder—Doxorubicin—sarcoma	6.21e-05	0.000346	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—sarcoma	6.18e-05	0.000345	CcSEcCtD
Ofloxacin—Chest pain—Epirubicin—sarcoma	6.15e-05	0.000344	CcSEcCtD
Ofloxacin—Arthralgia—Epirubicin—sarcoma	6.15e-05	0.000344	CcSEcCtD
Ofloxacin—Myalgia—Epirubicin—sarcoma	6.15e-05	0.000344	CcSEcCtD
Ofloxacin—Agitation—Doxorubicin—sarcoma	6.15e-05	0.000343	CcSEcCtD
Ofloxacin—Anxiety—Epirubicin—sarcoma	6.13e-05	0.000342	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	6.11e-05	0.000341	CcSEcCtD
Ofloxacin—Discomfort—Epirubicin—sarcoma	6.08e-05	0.000339	CcSEcCtD
Ofloxacin—Malaise—Doxorubicin—sarcoma	6.03e-05	0.000337	CcSEcCtD
Ofloxacin—Dry mouth—Epirubicin—sarcoma	6.02e-05	0.000336	CcSEcCtD
Ofloxacin—Vertigo—Doxorubicin—sarcoma	6.01e-05	0.000335	CcSEcCtD
Ofloxacin—Syncope—Doxorubicin—sarcoma	6e-05	0.000335	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—sarcoma	5.99e-05	0.000334	CcSEcCtD
Ofloxacin—Confusional state—Epirubicin—sarcoma	5.95e-05	0.000332	CcSEcCtD
Ofloxacin—Palpitations—Doxorubicin—sarcoma	5.91e-05	0.00033	CcSEcCtD
Ofloxacin—Anaphylactic shock—Epirubicin—sarcoma	5.9e-05	0.000329	CcSEcCtD
Ofloxacin—Oedema—Epirubicin—sarcoma	5.9e-05	0.000329	CcSEcCtD
Ofloxacin—Loss of consciousness—Doxorubicin—sarcoma	5.88e-05	0.000328	CcSEcCtD
Ofloxacin—Infection—Epirubicin—sarcoma	5.86e-05	0.000327	CcSEcCtD
Ofloxacin—Cough—Doxorubicin—sarcoma	5.84e-05	0.000326	CcSEcCtD
Ofloxacin—Shock—Epirubicin—sarcoma	5.8e-05	0.000324	CcSEcCtD
Ofloxacin—Nervous system disorder—Epirubicin—sarcoma	5.79e-05	0.000323	CcSEcCtD
Ofloxacin—Thrombocytopenia—Epirubicin—sarcoma	5.78e-05	0.000322	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—sarcoma	5.77e-05	0.000322	CcSEcCtD
Ofloxacin—Tachycardia—Epirubicin—sarcoma	5.76e-05	0.000321	CcSEcCtD
Ofloxacin—Skin disorder—Epirubicin—sarcoma	5.73e-05	0.00032	CcSEcCtD
Ofloxacin—Hyperhidrosis—Epirubicin—sarcoma	5.7e-05	0.000318	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—sarcoma	5.69e-05	0.000318	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—sarcoma	5.69e-05	0.000318	CcSEcCtD
Ofloxacin—Arthralgia—Doxorubicin—sarcoma	5.69e-05	0.000318	CcSEcCtD
Ofloxacin—Anxiety—Doxorubicin—sarcoma	5.67e-05	0.000317	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	5.65e-05	0.000316	CcSEcCtD
Ofloxacin—Discomfort—Doxorubicin—sarcoma	5.63e-05	0.000314	CcSEcCtD
Ofloxacin—Anorexia—Epirubicin—sarcoma	5.62e-05	0.000314	CcSEcCtD
Ofloxacin—Dry mouth—Doxorubicin—sarcoma	5.57e-05	0.000311	CcSEcCtD
Ofloxacin—Hypotension—Epirubicin—sarcoma	5.51e-05	0.000308	CcSEcCtD
Ofloxacin—Confusional state—Doxorubicin—sarcoma	5.5e-05	0.000307	CcSEcCtD
Ofloxacin—Oedema—Doxorubicin—sarcoma	5.46e-05	0.000305	CcSEcCtD
Ofloxacin—Anaphylactic shock—Doxorubicin—sarcoma	5.46e-05	0.000305	CcSEcCtD
Ofloxacin—Infection—Doxorubicin—sarcoma	5.42e-05	0.000303	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Epirubicin—sarcoma	5.37e-05	0.0003	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—sarcoma	5.37e-05	0.0003	CcSEcCtD
Ofloxacin—Nervous system disorder—Doxorubicin—sarcoma	5.35e-05	0.000299	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—sarcoma	5.34e-05	0.000298	CcSEcCtD
Ofloxacin—Insomnia—Epirubicin—sarcoma	5.34e-05	0.000298	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—sarcoma	5.33e-05	0.000297	CcSEcCtD
Ofloxacin—Skin disorder—Doxorubicin—sarcoma	5.3e-05	0.000296	CcSEcCtD
Ofloxacin—Paraesthesia—Epirubicin—sarcoma	5.3e-05	0.000296	CcSEcCtD
Ofloxacin—Hyperhidrosis—Doxorubicin—sarcoma	5.28e-05	0.000295	CcSEcCtD
Ofloxacin—Dyspnoea—Epirubicin—sarcoma	5.26e-05	0.000294	CcSEcCtD
Ofloxacin—Somnolence—Epirubicin—sarcoma	5.24e-05	0.000293	CcSEcCtD
Ofloxacin—Anorexia—Doxorubicin—sarcoma	5.2e-05	0.00029	CcSEcCtD
Ofloxacin—Dyspepsia—Epirubicin—sarcoma	5.19e-05	0.00029	CcSEcCtD
Ofloxacin—Decreased appetite—Epirubicin—sarcoma	5.13e-05	0.000286	CcSEcCtD
Ofloxacin—Hypotension—Doxorubicin—sarcoma	5.1e-05	0.000285	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Epirubicin—sarcoma	5.09e-05	0.000284	CcSEcCtD
Ofloxacin—Fatigue—Epirubicin—sarcoma	5.09e-05	0.000284	CcSEcCtD
Ofloxacin—Constipation—Epirubicin—sarcoma	5.04e-05	0.000282	CcSEcCtD
Ofloxacin—Pain—Epirubicin—sarcoma	5.04e-05	0.000282	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—sarcoma	4.97e-05	0.000278	CcSEcCtD
Ofloxacin—Insomnia—Doxorubicin—sarcoma	4.94e-05	0.000276	CcSEcCtD
Ofloxacin—Paraesthesia—Doxorubicin—sarcoma	4.9e-05	0.000274	CcSEcCtD
Ofloxacin—Dyspnoea—Doxorubicin—sarcoma	4.87e-05	0.000272	CcSEcCtD
Ofloxacin—Feeling abnormal—Epirubicin—sarcoma	4.86e-05	0.000271	CcSEcCtD
Ofloxacin—Somnolence—Doxorubicin—sarcoma	4.85e-05	0.000271	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Epirubicin—sarcoma	4.82e-05	0.000269	CcSEcCtD
Ofloxacin—Dyspepsia—Doxorubicin—sarcoma	4.8e-05	0.000268	CcSEcCtD
Ofloxacin—Decreased appetite—Doxorubicin—sarcoma	4.74e-05	0.000265	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—sarcoma	4.71e-05	0.000263	CcSEcCtD
Ofloxacin—Fatigue—Doxorubicin—sarcoma	4.71e-05	0.000263	CcSEcCtD
Ofloxacin—Urticaria—Epirubicin—sarcoma	4.69e-05	0.000262	CcSEcCtD
Ofloxacin—Constipation—Doxorubicin—sarcoma	4.67e-05	0.000261	CcSEcCtD
Ofloxacin—Pain—Doxorubicin—sarcoma	4.67e-05	0.000261	CcSEcCtD
Ofloxacin—Body temperature increased—Epirubicin—sarcoma	4.66e-05	0.00026	CcSEcCtD
Ofloxacin—Abdominal pain—Epirubicin—sarcoma	4.66e-05	0.00026	CcSEcCtD
Ofloxacin—Feeling abnormal—Doxorubicin—sarcoma	4.5e-05	0.000251	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Doxorubicin—sarcoma	4.46e-05	0.000249	CcSEcCtD
Ofloxacin—Hypersensitivity—Epirubicin—sarcoma	4.35e-05	0.000243	CcSEcCtD
Ofloxacin—Urticaria—Doxorubicin—sarcoma	4.34e-05	0.000242	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—sarcoma	4.31e-05	0.000241	CcSEcCtD
Ofloxacin—Body temperature increased—Doxorubicin—sarcoma	4.31e-05	0.000241	CcSEcCtD
Ofloxacin—Asthenia—Epirubicin—sarcoma	4.23e-05	0.000236	CcSEcCtD
Ofloxacin—Pruritus—Epirubicin—sarcoma	4.17e-05	0.000233	CcSEcCtD
Ofloxacin—Diarrhoea—Epirubicin—sarcoma	4.04e-05	0.000225	CcSEcCtD
Ofloxacin—Hypersensitivity—Doxorubicin—sarcoma	4.02e-05	0.000225	CcSEcCtD
Ofloxacin—Asthenia—Doxorubicin—sarcoma	3.92e-05	0.000219	CcSEcCtD
Ofloxacin—Dizziness—Epirubicin—sarcoma	3.9e-05	0.000218	CcSEcCtD
Ofloxacin—Pruritus—Doxorubicin—sarcoma	3.86e-05	0.000216	CcSEcCtD
Ofloxacin—Vomiting—Epirubicin—sarcoma	3.75e-05	0.000209	CcSEcCtD
Ofloxacin—Diarrhoea—Doxorubicin—sarcoma	3.73e-05	0.000208	CcSEcCtD
Ofloxacin—Rash—Epirubicin—sarcoma	3.72e-05	0.000208	CcSEcCtD
Ofloxacin—Dermatitis—Epirubicin—sarcoma	3.72e-05	0.000207	CcSEcCtD
Ofloxacin—Headache—Epirubicin—sarcoma	3.7e-05	0.000206	CcSEcCtD
Ofloxacin—Dizziness—Doxorubicin—sarcoma	3.61e-05	0.000202	CcSEcCtD
Ofloxacin—Nausea—Epirubicin—sarcoma	3.5e-05	0.000196	CcSEcCtD
Ofloxacin—Vomiting—Doxorubicin—sarcoma	3.47e-05	0.000194	CcSEcCtD
Ofloxacin—Rash—Doxorubicin—sarcoma	3.44e-05	0.000192	CcSEcCtD
Ofloxacin—Dermatitis—Doxorubicin—sarcoma	3.44e-05	0.000192	CcSEcCtD
Ofloxacin—Headache—Doxorubicin—sarcoma	3.42e-05	0.000191	CcSEcCtD
Ofloxacin—Nausea—Doxorubicin—sarcoma	3.24e-05	0.000181	CcSEcCtD
